Analysts Amryt Pharma is covered by the investment analysts listed below: Institution Analyst Contact Details Cantor Fitzgerald Brandon Folkes brandon.folkes@cantor.com Tel: +1 212 294 8081 Canaccord Genuity Michelle Gilson mgilson@cgf.com Tel: +1 212 389 8094 Stifel Nicolaus Max Herrmann max.herrmann@stifel.com Tel: +44 207 710 7606 Maxim Group Jason McCarthy jmccarthy@maximgrp.com Tel: +1 212 895 3556 Shore Capital Stockbrokers Ltd Adam Barker adam.barker@shorecap.co.uk Tel: +44 151 600 3707 H.C. Wainwright Douglas Tsao dtsao@hcwresearch.com Tel: +1 212 916 3698 Please note that any estimates, opinions or forecasts regarding Amryt Pharma’s performance offered by these analysts are their views alone and do not represent those of Amryt Pharma. We transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those in greatest need. Privacy policy | Terms and Conditions Cookie policy | Fraud warning Accessibility | Sitemap Website Last updated: 04/08/2021 | Copyright © 2021 Amryt Pharma plc We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. Cookie Settings Accept All

Reports and presentations Presentations Annual Reports Quarterly Reports Sec Filings REGISTER FOR ALERTS Presentations 23 November 2021 Amryt Pharma Corporate Overview November 2021 PDF 03 November 2021 Amryt Pharma Q3 2021 Analyst Call & Webcast PDF 13 September 2021 Amryt Virtual Capital Markets Event Presentation PDF 06 August 2021 Amryt Pharma Q2 2021 Analyst Call & Webcast PDF 05 May 2021 Amryt Pharma FY 2020 & Q1 2021 Analyst Call & Webcast PDF 24 Feb 2021 Rare and Ultra-Rare Diseases. Prioritisation and Sustainability – a Report from the Front-Line PDF 05 Nov 2020 Amryt Q3 2020 Analyst Call & Webcast PDF Annual Reports 29 Jun 2021 Amryt Pharma plc Annual Report 2020 PDF 30 Jun 2020 Amryt Pharma plc Annual Report 2019 PDF 12 Jun 2019 Amryt Pharma plc Annual Report 2018 PDF 04 May 2018 Amryt Pharma plc Annual Report 2017 PDF 06 Apr 2017 Amryt Pharma Annual Report 2016 PDF 10 Jun 2016 Amryt Pharma Annual Report 2015 PDF 04 Sep 2015 Annual Report as at 31.03.2015 PDF Quarterly Reports 03 Nov 2021 Q3 2021 Results 06 Aug 2021 Q2 2021 Results 05 May 2021 Q1 2021 Results 04 Mar 2021 Q4 2020 Results 05 Nov 2020 Q3 2020 Results 06 Aug 2020 Q2 2020 Results 11 May 2020 Q1 2020 Results Sec Filings We transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those in greatest need. Privacy policy | Terms and Conditions Cookie policy | Fraud warning Accessibility | Sitemap Website Last updated: 04/08/2021 | Copyright © 2021 Amryt Pharma plc We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. Cookie Settings Accept All